6.27.19
6 min. read

Omada’s strategy. Boehringer invests in myopia DTx.

Issue 008. Omada's strategy. Boehringer invests in myopia DTx.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a respectable 83 percent open rate. Here's what's happening this week:

  •  Your editor survived camping with the 3- and 5-year-old last weekend and is now preparing to add a large canine, named Moose, to the family. Hit reply to send training tips or dog treats my way.
  • De-identified vs. re-identifiable: A class-action lawsuit alleges that the University of Chicago and its medical center shared hundreds of thousands of patients’ records with its partner, Google, without removing identifiable date stamps or physicians' notes.
  • As expected, PatientsLikeMe finally found a buyer after the Feds forced its majority owner, China-based iCarbonX, to divest. UnitedHealth snapped it up. ePatient Dave has a worthwhile

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Recent Articles